Search Results

Karine Pichavant , I contributed to the development of a drug to treat hypovolemic shock after severe Chemistry which described the molecular mechanisms of MRAP2 regulation of the GHSR1a, and where I notably developed I also invested a tremendous amount of time in developing my leadership skills.

pharmacological chaperones, his work on bioluminescence resonance energy transfer (BRET) resulted in the development a member of the lab, I am humbled to have been able to work with him and his team and use the tools developed

Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and Development

He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new

They also explored the possibility of developing an ecosystem for the GPCR University. Developing a Research Ecosystem at GPCR University Yamina and Claudia discussed developing an ecosystem

affinity experiments are interpreted—and how those interpretations quietly shape SAR, lead selection, and development Every week, our team curates the most important developments so you never miss a breakthrough, opportunity

He also discovered and championed a novel prostaglandin EP4 drug candidate for development.

nervous system disorders realm to understand the neurobiology of neuropsychiatric disorders and to develop

Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and Development

To further develop these ideas, I joined the lab of Dr. John's Chemistry Olympiad Journey John shared his experiences in high school, where he developed a keen working on a project involving receptor kinases and collaborating with other postdocs in the lab to develop John suggested starting preparations a year to two years ahead due to the time needed to develop ideas

His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with

A large component of his work is centered around dysregulated signaling in cancer and the development

information on dysregulated signaling circuitries and individual genomic and molecular alterations to develop

David Tuveson at CSHL where he participated in the development of an organoid system for the culture normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker development He also continued his interest in computational analysis of cancer drivers by co-developing GECCO, an Mike shared his strategy of developing preliminary projects and gathering data to strengthen his application

Yekkirala shares the pivotal moments that transformed him from a curious PhD student into a GPCR drug developer scientists interested in translational innovation Biotech investors and strategic leaders seeking new drug development

medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry, during which she developed

We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring

(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software

Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

Get it wrong, and the best molecule on paper stalls in development.

Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build a lab that develops He aspires to become a physician-scientist, with a focus on translational in vitro and in vivo model development Other academic interests of his include studying pharmaceutical finance & healthcare administration and developing

She developed expertise over the past two decades studying structure/function relationships of GPCRs

Ecosystem.DrGPCR.com may use this information to customize the advertising and content you see and to If you want to opt out of Google Analytics for Display Advertising, customize Google Display Network

His journey highlights the transition from general drug development to a deep dive into G protein-coupled mentorship, open communication, and peer learning — especially from undergraduate trainees — shape his development Clements' work is primarily focused on translational developments of small molecule therapeutics, and

He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination

She is an internationally recognized biophysicist for her contributions in developing constrained molecular

co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development

He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor

Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class